BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1377290)

  • 21. Prostate-specific antigen: insufficient discrimination between benign prostatic hyperplasia and organ-confined prostate cancer.
    Wolff JM; Boeckmann W; Borchers H; Handt S; Reineke T; Jakse G
    Urol Int; 1996; 57(3):170-4. PubMed ID: 8912446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term effect of digital rectal examination on serum prostate-specific antigen levels. A prospective study.
    Cevik I; Türkeri LN; Ozveri H; Ilker Y; Akdaş A
    Eur Urol; 1996; 29(4):403-6. PubMed ID: 8791045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
    Presti JC; Hovey R; Carroll PR; Shinohara K
    J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels.
    Ornstein DK; Rao GS; Smith DS; Ratliff TL; Basler JW; Catalona WJ
    J Urol; 1997 Jan; 157(1):195-8. PubMed ID: 8976249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
    Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
    S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.
    Oesterling JE
    J Urol; 1991 May; 145(5):907-23. PubMed ID: 1707989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA, and prostate health index in men with a total prostate-specific antigen of 4-10 ng/ml and normal digital rectal examination.
    Lazzeri M; Abrate A; Lughezzani G; Gadda GM; Freschi M; Mistretta F; Lista G; Fossati N; Larcher A; Kinzikeeva E; Buffi N; Dell'Acqua V; Bini V; Montorsi F; Guazzoni G
    Urology; 2014 Mar; 83(3):606-12. PubMed ID: 24315305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.
    Ellis WJ; Chetner MP; Preston SD; Brawer MK
    J Urol; 1994 Nov; 152(5 Pt 1):1520-5. PubMed ID: 7523710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
    Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria.
    Udeh EI; Nnabugwu II; Ozoemena FO; Ugwumba FO; Aderibigbe AS; Ohayi SR; Echetabu KN
    World J Surg Oncol; 2016 Jun; 14(1):174. PubMed ID: 27356753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of digital rectal examination on prostate-specific antigen levels.
    Crawford ED; Schutz MJ; Clejan S; Drago J; Resnick MI; Chodak GW; Gomella LG; Austenfeld M; Stone NN; Miles BJ
    JAMA; 1992 Apr 22-29; 267(16):2227-8. PubMed ID: 1372943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age.
    Babaian RJ; Miyashita H; Evans RB; Ramirez EI
    J Urol; 1992 Mar; 147(3 Pt 2):837-40. PubMed ID: 1371558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
    Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
    Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less.
    Carvalhal GF; Smith DS; Mager DE; Ramos C; Catalona WJ
    J Urol; 1999 Mar; 161(3):835-9. PubMed ID: 10022696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of prostate cancer: comparison of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.
    Tsui KH; Chang PL; Wang TM; Hsieh ML
    Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):23-8. PubMed ID: 9178589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Findings of the American Cancer Society National Prostate Cancer Detection Project.
    Kane RA; Littrup PJ; Babaian R; Drago JR; Lee F; Chesley A; Murphy GP; Mettlin C
    Cancer; 1992 Mar; 69(5):1201-7. PubMed ID: 1371234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of percent free prostate-specific antigen density to improve the specificity for detecting prostate cancer in patients with normal rectal examinations and intermediate prostate-specific antigen levels.
    Baltaci S; Aksoy H; Türkölmez K; Elhan AH; Ozden E; Göğüş O
    Urol Int; 2003; 70(1):36-41. PubMed ID: 12566813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer detection at low prostate specific antigen.
    Schröder FH; van der Cruijsen-Koeter I; de Koning HJ; Vis AN; Hoedemaeker RF; Kranse R
    J Urol; 2000 Mar; 163(3):806-12. PubMed ID: 10687982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Status of PSA determination for early detection of prostate carcinoma].
    Hammerer P; Huland H
    Versicherungsmedizin; 1995 Jun; 47(3):83-6. PubMed ID: 7541925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
    De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
    Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.